Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia

Clinical trial NCT00608985 · COMPLETED

Trial details

NCT number: NCT00608985
Sponsor: Midnight Pharma, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Insomnia

Start date: 2008-03-01
Primary completion: 2009-09-01
Enrollment: 709

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.